Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00967941 · ClinicalTrials.gov registry record
Vancomycin and Daptomycin Plus Cefazolin for Preoperative Vascular Surgery Prophylaxis
A clinical trial, sponsored by CAMC Health System.
- Completed
- Registry status
- 169
- Enrollment target
NCT00967941 is a clinical trial that has completed, run by CAMC Health System. The registered enrollment target is 169 participants.
The verdict
NCT00967941 has completed, sponsored by CAMC Health System.
- COMPLETED
- Registry status
- 169 participants
- Enrollment target
Study Summary
This study prospectively selects the patients to examine the effectiveness of the investigators' current standard of prophylaxis prior to vascular surgery and to compare the effectiveness of vancomycin and daptomycin plus cefazolin in reducing infections in vascular surgical patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 169 participants |
| Start Date | 2007-08 |
| Est. Completion | 2010-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00967941
The ClinicalTrials.gov registry entry for NCT00967941 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 169 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CAMC Health System, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00967941 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00967941 about?
NCT00967941 is a clinical study titled "Vancomycin and Daptomycin Plus Cefazolin for Preoperative Vascular Surgery Prophylaxis". This study prospectively selects the patients to examine the effectiveness of the investigators' current standard of prophylaxis prior to vascular surgery and to compare the effectiveness of vancomycin and daptomycin plus cefazolin in reducing infections in vascular surgical patients.
What is the current status of trial NCT00967941?
This trial is currently completed. The enrollment target is 169 participants. The study started on 2007-08. Estimated completion is 2010-08.
Who is sponsoring clinical trial NCT00967941?
This trial is sponsored by CAMC Health System, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.